Ποια είναι η τιμή για Novogene Co., Ltd. (688315)

Η τιμή για Novogene Co., Ltd. (688315) είναι $2.25

Ποια είναι η κεφαλαιοποίηση αγοράς για Novogene Co., Ltd. (688315)

Η κεφαλαιοποίηση αγοράς για Novogene Co., Ltd. (688315) είναι $936.66M

Novogene Co., Ltd. (688315) Τιμή και Κεφαλαιοποίηση Αγοράς

Novogene Co., Ltd. is a global provider of comprehensive genomic services and advanced solutions. Its offerings span a wide array of genomic applications, including human, animal, plant, and microbial genome sequencing, alongside gene regulation and single-cell sequencing technologies. The company also specializes in cancer genomic profiling, whole exome sequencing (including clinical-grade versions), and FFPE RNA sequencing. Furthermore, Novogene develops proprietary tools such as NovoFocus, a next-generation sequencing (NGS)-based companion diagnostic for PARP inhibitor treatments, and NovoNeoantigen, a bioinformatics pipeline that identifies cancer neoantigens by analyzing whole exome and whole transcriptome sequencing data from matched tumor and normal samples. In a strategic collaboration, Novogene partners with Hummingbird Bioscience Pte. Ltd. to aid in the advancement of HMBD-001. This investigational anti-HER3 antibody is being assessed for its potential to treat diverse cancer types, notably those driven by NRG1-fusion. Established in 2011, Novogene Co., Ltd. operates from its headquarters in Beijing, China.

Η τιμή για 688315	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$12,647.45 $936.66M	NVDA	$5.264T	+561,880.73%
$11,295.71 $936.66M	AAPL	$4.701T	+501,817.34%
$10,036.47 $936.66M	GOOG	$4.177T	+445,863.60%
$9,172.04 $936.66M	MSFT	$3.817T	+407,453.15%
$6,886.92 $936.66M	AMZN	$2.866T	+305,915.68%

Η τιμή για 688315

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$12,647.45 $936.66M